Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Hedia logo — Our vision is to improve quality of life for people with dia...

Hedia

Our vision is to improve quality of life for people with diabetes and make the best diabetes management tools available.

Founded 2015 Denmark Denmark 43 employees Seed Total: $35.07M AI, Life Sciences +1

General Information

Company Name Hedia
Founded Year 2015
Location Denmark Denmark +1
Employees 43
Industries AI, Life Sciences, Medical Devices
Funding Stage Seed
Social

Get notified when Hedia moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hedia

Hedia is a Danish startup with a vision to improve the quality of life for people with diabetes by making the best diabetes management tools accessible to a wider audience. Their flagship product, the Hedia Diabetes Assistant (HDA), is a class IIb medical device designed to enhance the management of insulin-requiring diabetes and stabilize blood glucose levels. By analyzing individual habits and personalized input, HDA provides tailored insulin recommendations, thus assisting individuals with their treatment. In addition to their diabetes management tool, Hedia also offers an education platform for healthcare professionals. Founded in 2015, Hedia operates in the fields of AI, Life Sciences, and Medical Devices. Their recent milestone includes a kr22.50M Seed Round investment on 23 February 2024. Although the specific investors for this round are not mentioned, the company has developed its platform in close collaboration with patients, nurses, and other key stakeholders to ensure a fit for living with diabetes. Hedia's vision and strategic positioning in the healthcare industry make it a promising contender in the diabetes management landscape.

Taxonomy: Diabetes Management, Medical Device, Healthcare Professionals Education, Insulin Recommendations, Patient-Centric Solution, Personalized Healthcare, Chronic Disease Management, AI-Powered Healthcare, Patient Engagement, Healthcare Innovation

Services & Products

Development and distribution of the Hedia Diabetes Assistant
a class IIb medical device designed to support the management of insulin-requiring diabetes. Additionally
collaboration with partners in the diabetes ecosystem.

Target Customers

Patients with insulin-requiring diabetes healthcare professionals clinics hospitals and industry leaders within the diabetes care space.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• - 23 Feb 2024
Seed Round •••••• - 23 Dec 2021
Seed Round •••••• - 01 Nov 2020
Seed Round •••••• - 01 Jul 2019
Grant •••••• 1 •••• •••• 01 Jan 2019

View All 7 Funding Rounds

Hedia Alternatives & Competitors

Hedia vs
IBD Medical
IBD Medical Australia

Improving the lives of people living with diabetes by making diabetes management easier, faster, and...

12 employees
Health Care, Platforms
Compare Hedia vs IBD Medical
Hedia vs
Diatech Diabetes, Inc.
Diatech Diabetes, Inc. United States

Personalizing Insulin Delivery for People with Diabetes

Debt Financing
7 employees
Health Care, Medical Devices
Compare Hedia vs Diatech Diabetes, Inc.
Hedia vs
Valeritas
Valeritas United States

Improving health and simplifying life for people with diabetes.

Series Unknown
35 employees
Biotechnology, Health Care
Compare Hedia vs Valeritas

FAQ About Hedia

Our vision is to improve quality of life for people with diabetes and make the best diabetes management tools available.
Hedia was founded in 2015.
Hedia is headquartered in Denmark.
Hedia operates in the following industries: AI, Life Sciences, Medical Devices.
Hedia has approximately 43 employees.
Hedia has completed 7 funding rounds, raising a total of $35.07M. The latest funding stage is Seed.
Hedia offers: Development and distribution of the Hedia Diabetes Assistant, a class IIb medical device designed to support the management of insulin-requiring diabetes. Additionally, collaboration with partners in the diabetes ecosystem..
Top alternatives and competitors to Hedia include IBD Medical, Diatech Diabetes, Inc., Valeritas, Bigfoot Biomedical, Pacific Diabetes Technologies Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hedia and IBD Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hedia and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy